Back to ERNA

Eterna Therapeutics Inc. 10-Q

Accession 0001140361-22-024669

Filing information

CIK
0000748592
Report date
2022-03-31
Filing date
2022-07-01
Form
10-Q
Primary document
brhc10039260_10q.htm

Open primary document

View the filing document on sec.gov.

Open EDGAR directory

Inspect all files for this filing.

Complete submission file

Open the raw SEC submission text.